Pharmacology of Vanilloid Transient Receptor Potential Cation Channels

With the recent clinical success of drugs targeting protein kinase activity, drug discovery efforts are focusing on the role of reversible protein phosphorylation in disease states. The activity of protein phosphatases, enzymes that oppose protein kinases, can also be manipulated to alter cellular signaling for therapeutic benefits. In this review, we present protein serine/threonine phosphatases as viable therapeutic targets, discussing past successes, current challenges, and future strategies for modulating phosphatase activity.

[1]  J. Tytgat,et al.  Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels , 2006, FEBS letters.

[2]  V. Tumiatti,et al.  Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons. , 2004, European journal of pharmacology.

[3]  B. Nilius,et al.  Transient receptor potential channels meet phosphoinositides , 2008, The EMBO journal.

[4]  D. Barford,et al.  The structure and mechanism of protein phosphatases: insights into catalysis and regulation. , 1998, Annual review of biophysics and biomolecular structure.

[5]  S. Hwang,et al.  Transient receptor potential V2 expressed in sensory neurons is activated by probenecid , 2007, Neuroscience Letters.

[6]  J. Bushweller,et al.  Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action. , 2005, Biochemistry.

[7]  W. Hahn,et al.  Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. , 2003, Cancer cell.

[8]  H. Hofer,et al.  Tyrosine phosphatase PTP1B interacts with TRPV6 in vivo and plays a role in TRPV6-mediated calcium influx in HEK293 cells. , 2005, Cellular signalling.

[9]  A. Chamberlin,et al.  Activation of protein phosphatase 1 by a small molecule designed to bind to the enzyme's regulatory site. , 2008, Chemistry & biology.

[10]  R. Blakely,et al.  Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A , 2000, The Journal of Neuroscience.

[11]  J. Chen,et al.  Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. , 1992, Science.

[12]  A. Silverstein,et al.  The Tetratricopeptide Repeat Domain of Protein Phosphatase 5 Mediates Binding to Glucocorticoid Receptor Heterocomplexes and Acts as a Dominant Negative Mutant* , 1996, The Journal of Biological Chemistry.

[13]  Heribert Hirt,et al.  Plant PP2C phosphatases: emerging functions in stress signaling. , 2004, Trends in plant science.

[14]  G. Appendino,et al.  A Convenient Synthesis of 5′-Iodoresiniferatoxin (I-RTX) , 2006 .

[15]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[16]  M. Tominaga,et al.  Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins , 2005, Molecular pain.

[17]  David Julius,et al.  Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers , 2002, Cell.

[18]  M. Caterina,et al.  5-Iodoresiniferatoxin Evokes Hypothermia in Mice and Is a Partial Transient Receptor Potential Vanilloid 1 Agonist in Vitro , 2005, Journal of Pharmacology and Experimental Therapeutics.

[19]  L. Islas,et al.  On the mechanism of TBA block of the TRPV1 channel. , 2007, Biophysical journal.

[20]  G. Wang,et al.  Medical uses of mylabris in ancient China and recent studies. , 1989, Journal of ethnopharmacology.

[21]  P. Blumberg,et al.  Thapsigargin binds to and inhibits the cloned vanilloid receptor-1. , 2002, Biochemical and biophysical research communications.

[22]  D. W. Fry,et al.  The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity. , 1985, Advances in Enzyme Regulation.

[23]  Huong T. T. Pham,et al.  Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene , 2001, Oncogene.

[24]  Pierangelo Geppetti,et al.  An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Randall,et al.  Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1) , 2005, British journal of pharmacology.

[26]  A. Szallasi,et al.  The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept , 2007, Nature Reviews Drug Discovery.

[27]  A. Basbaum,et al.  Immunoreactive TRPV‐2 (VRL‐1), a capsaicin receptor homolog, in the spinal cord of the rat , 2004, The Journal of comparative neurology.

[28]  W. Hahn,et al.  Multiple pathways regulated by the tumor suppressor PP2A in transformation. , 2008, Trends in molecular medicine.

[29]  D. Mohapatra,et al.  A tyrosine residue in TM6 of the Vanilloid Receptor TRPV1 involved in desensitization and calcium permeability of capsaicin-activated currents , 2003, Molecular and Cellular Neuroscience.

[30]  A. Saltiel,et al.  Lipid phosphatases as drug discovery targets for type 2 diabetes , 2006, Nature Reviews Drug Discovery.

[31]  M. Mumby,et al.  Control of protein phosphatase 2A by simian virus 40 small-t antigen , 1991, Molecular and cellular biology.

[32]  J. Yates,et al.  Attenuation of a phosphorylation-dependent activator by an HDAC–PP1 complex , 2003, Nature Structural Biology.

[33]  S. Christakos,et al.  Phospholipase C-Mediated Regulation of Transient Receptor Potential Vanilloid 6 Channels: Implications in Active Intestinal Ca2+ Transport , 2009, Molecular Pharmacology.

[34]  S. Ackland,et al.  Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation. , 2007, Bioorganic & medicinal chemistry.

[35]  G. Ahern,et al.  Polyamines Are Potent Ligands for the Capsaicin Receptor TRPV1* , 2006, Journal of Biological Chemistry.

[36]  J. Casida,et al.  Cantharidin-binding protein: identification as protein phosphatase 2A. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Tonks,et al.  Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.

[38]  T. Bíró,et al.  The Analgesic Drug, Tramadol, Acts as an Agonist of the Transient Receptor Potential Vanilloid-1 , 2008, Anesthesia and analgesia.

[39]  T. Pawson,et al.  Mutational activation of c-raf-1 and definition of the minimal transforming sequence , 1990, Molecular and cellular biology.

[40]  A. Patapoutian,et al.  More than cool: Promiscuous relationships of menthol and other sensory compounds , 2006, Molecular and Cellular Neuroscience.

[41]  E. Harhaj,et al.  Activation of NF-κB by Phosphatase Inhibitors Involves the Phosphorylation of IκBα at Phosphatase 2A-sensitive Sites (*) , 1995, The Journal of Biological Chemistry.

[42]  C. Foged,et al.  Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. , 2001, Molecular pharmacology.

[43]  Chih-Hung Lee,et al.  Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists. , 2008, Bioorganic & medicinal chemistry.

[44]  J. T. Corwin,et al.  Lighting up the Senses: FM1-43 Loading of Sensory Cells through Nonselective Ion Channels , 2003, The Journal of Neuroscience.

[45]  Ellen A. Lumpkin,et al.  Spider toxins activate the capsaicin receptor to produce inflammatory pain , 2006, Nature.

[46]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[47]  T. Brennan,et al.  Effect of AMG0347, a Transient Receptor Potential Type V1 Receptor Antagonist, and Morphine on Pain Behavior after Plantar Incision , 2008, Anesthesiology.

[48]  B. Nilius,et al.  Invertebrate TRP proteins as functional models for mammalian channels , 2004, Pflügers Archiv.

[49]  M. Sodeoka,et al.  Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode. , 2005, Bioorganic & medicinal chemistry.

[50]  L. Donehower,et al.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.

[51]  J. Pomonis,et al.  N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[52]  M. Iadarola,et al.  Cyclin-dependent kinase 5 activity regulates pain signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Shenolikar,et al.  Importance of the β12-β13 Loop in Protein Phosphatase-1 Catalytic Subunit for Inhibition by Toxins and Mammalian Protein Inhibitors* , 1999, The Journal of Biological Chemistry.

[54]  V. Flockerzi,et al.  Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives* , 2002, The Journal of Biological Chemistry.

[55]  S. V. D. van de Graaf,et al.  Molecular Identification of the Apical Ca2+Channel in 1,25-Dihydroxyvitamin D3-responsive Epithelia* , 1999, The Journal of Biological Chemistry.

[56]  Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development. , 2006, Bioorganic & medicinal chemistry letters.

[57]  Vladimir A. Pavlyukovets,et al.  Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists. , 2005, Bioorganic & medicinal chemistry letters.

[58]  D. Clapham,et al.  An introduction to TRP channels. , 2006, Annual review of physiology.

[59]  C. Bountra,et al.  The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons , 2006, Neuroscience Letters.

[60]  T. Fukuoka,et al.  Possible Involvement of P2Y2 Metabotropic Receptors in ATP-Induced Transient Receptor Potential Vanilloid Receptor 1-Mediated Thermal Hypersensitivity , 2003, The Journal of Neuroscience.

[61]  A. Surprenant.  Pain TRP‐ed up by PARs , 2007, The Journal of physiology.

[62]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[63]  Kun-Liang Guan,et al.  Mechanisms of regulating the Raf kinase family. , 2003, Cellular signalling.

[64]  E. Collins,et al.  Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. , 2000, Bioorganic & medicinal chemistry letters.

[65]  M. Mumby,et al.  Effects of regulatory subunits on the kinetics of protein phosphatase 2A. , 2000, Biochemistry.

[66]  G. Ahern,et al.  TRPV1 is a novel target for omega‐3 polyunsaturated fatty acids , 2007, The Journal of physiology.

[67]  M. Beeram,et al.  Raf: a strategic target for therapeutic development against cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  A. Rebollo,et al.  Use of Penetrating Peptides Interacting with PP1/PP2A Proteins As a General Approach for a Drug Phosphatase Technology , 2006, Molecular Pharmacology.

[69]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[70]  Robert S. Carter,et al.  Positive Regulation of IκB Kinase Signaling by Protein Serine/Threonine Phosphatase 2A* , 2005, Journal of Biological Chemistry.

[71]  C. Davies,et al.  Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist , 2004, Neuropharmacology.

[72]  L. Petrocellis,et al.  Analgesic actions of N‐arachidonoyl‐serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors , 2007, British journal of pharmacology.

[73]  B. Nilius,et al.  Structure-function relationship of the TRP channel superfamily. , 2006, Reviews of physiology, biochemistry and pharmacology.

[74]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[75]  B. Nilius,et al.  TRP channels: an overview. , 2005, Cell calcium.

[76]  Richard E Middleton,et al.  Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain. , 2004, Biochemistry.

[77]  S. Ito,et al.  Novel agonistic action of mustard oil on recombinant and endogenous porcine transient receptor potential V1 (pTRPV1) channels. , 2007, Biochemical pharmacology.

[78]  F. Ebner,et al.  Brain protein phosphatase 2A: Developmental regulation and distinct cellular and subcellular localization by B subunits , 1998, The Journal of comparative neurology.

[79]  R. Rodriguiz,et al.  A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior , 2008, Cell.

[80]  A. Nairn,et al.  The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity. , 1999, Bioorganic & medicinal chemistry.

[81]  F. Macian,et al.  NFAT proteins: key regulators of T-cell development and function , 2005, Nature Reviews Immunology.

[82]  R. Honkanen,et al.  Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. , 2007, Methods in molecular biology.

[83]  S. V. D. van de Graaf,et al.  Regulation of TRPV5 and TRPV6 by associated proteins. , 2006, American journal of physiology. Renal physiology.

[84]  H. Hofer,et al.  Inhibition of protein tyrosine phosphatase 1B by reactive oxygen species leads to maintenance of Ca2+ influx following store depletion in HEK 293 cells. , 2006, Cell calcium.

[85]  P. Illés,et al.  The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. , 2002, The Journal of pharmacology and experimental therapeutics.

[86]  Michael Chinkers,et al.  Identification of potential physiological activators of protein phosphatase 5. , 2002, Biochemistry.

[87]  A. Minassi,et al.  The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination. , 2005, Journal of medicinal chemistry.

[88]  S. Hwang,et al.  Capsaicin Binds to the Intracellular Domain of the Capsaicin-Activated Ion Channel , 1999, The Journal of Neuroscience.

[89]  G. Walter,et al.  Binding Specificity of Protein Phosphatase 2A Core Enzyme for Regulatory B Subunits and T Antigens , 1999, Journal of Virology.

[90]  K. Chiba.  FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. , 2005, Pharmacology & therapeutics.

[91]  K. Jacobson,et al.  Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1). , 2008, Bioorganic & medicinal chemistry.

[92]  Bernd Nilius,et al.  TRP channels: a TR(I)P through a world of multifunctional cation channels , 2005, Pflügers Archiv.

[93]  J. Redondo,et al.  Inhibitors of the calcineurin/NFAT pathway. , 2004, Current medicinal chemistry.

[94]  S. Cha,et al.  Protein kinase C inhibits caveolae-mediated endocytosis of TRPV5. , 2008, American journal of physiology. Renal physiology.

[95]  Matthew H. Brush,et al.  Deactylase Inhibitors Disrupt Cellular Complexes Containing Protein Phosphatases and Deacetylases* , 2004, Journal of Biological Chemistry.

[96]  A. Szallasi,et al.  TRPV1: a therapeutic target for novel analgesic drugs? , 2006, Trends in molecular medicine.

[97]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[98]  A. Minassi,et al.  N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor. , 2002, Journal of medicinal chemistry.

[99]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[100]  É. Szőke,et al.  Actions of 3-methyl-N-oleoyldopamine, 4-methyl-N-oleoyldopamine and N-oleoylethanolamide on the rat TRPV1 receptor in vitro and in vivo. , 2008, Life sciences.

[101]  D. Julius,et al.  A capsaicin-receptor homologue with a high threshold for noxious heat , 1999, Nature.

[102]  J. Hoenderop,et al.  Extracellular pH Dynamically Controls Cell Surface Delivery of Functional TRPV5 Channels , 2006, Molecular and Cellular Biology.

[103]  M. Kawada,et al.  Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells. , 2003, International immunopharmacology.

[104]  P. McIntyre,et al.  The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[105]  S C Sun,et al.  Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. , 1995, The Journal of biological chemistry.

[106]  H. Schaller,et al.  The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC. , 2001, Journal of cell science.

[107]  Jiyoun Lee,et al.  High affinity antagonists of the vanilloid receptor. , 2002, Molecular pharmacology.

[108]  R. Honkanen.  Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A , 1993, FEBS letters.

[109]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[110]  L. Vyklický,et al.  Reducing and Oxidizing Agents Sensitize Heat-Activated Vanilloid Receptor (TRPV1) Current , 2006, Molecular Pharmacology.

[111]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[112]  K. Swartz,et al.  An inhibitor of TRPV1 channels isolated from funnel Web spider venom. , 2005, Biochemistry.

[113]  R. Penner,et al.  CaT1 and the Calcium Release-activated Calcium Channel Manifest Distinct Pore Properties* , 2001, The Journal of Biological Chemistry.

[114]  A. Minassi,et al.  Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety. , 2007, Bioorganic & medicinal chemistry letters.

[115]  H. Watanabe,et al.  Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[116]  A. Stein,et al.  Phosphoinositide 3-Kinase Binds to TRPV1 and Mediates NGF-stimulated TRPV1 Trafficking to the Plasma Membrane , 2006, The Journal of general physiology.

[117]  Huong T. T. Pham,et al.  Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the Aβ subunit gene , 2001, Oncogene.

[118]  A. Bielawska,et al.  Long Chain Ceramides Activate Protein Phosphatase-1 and Protein Phosphatase-2A , 1999, The Journal of Biological Chemistry.

[119]  Tao Zhou,et al.  Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1 , 2008, Nature Immunology.

[120]  N. Harrison,et al.  Sensitization of Nociceptive Ion Channels by Inhaled Anesthetics—A Pain in the Gas? , 2008, Molecular Pharmacology.

[121]  Qing Tian,et al.  Role of Serine/Threonine Protein Phosphatase in Alzheimer’s Disease , 2002, Neurosignals.

[122]  S. Rossie,et al.  The Dimeric and Catalytic Subunit Forms of Protein Phosphatase 2A from Rat Brain Are Stimulated by C2-Ceramide (*) , 1995, The Journal of Biological Chemistry.

[123]  R. Sears,et al.  Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[124]  A. Bielawska,et al.  The structural requirements for ceramide activation of serine-threonine protein phosphatases Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300347-JLR200 , 2004, Journal of Lipid Research.

[125]  A. McCluskey,et al.  Protein phosphatase inhibition: structure based design. Towards new therapeutic agents. , 2004, Current pharmaceutical design.

[126]  M. Picciotto.  Faculty Opinions recommendation of A beta-arrestin 2 signaling complex mediates lithium action on behavior. , 2008 .

[127]  P. Lin,et al.  A Novel RNA Polymerase II C-terminal Domain Phosphatase That Preferentially Dephosphorylates Serine 5* , 2003, Journal of Biological Chemistry.

[128]  T. B. Miller,et al.  Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A , 1990, Cell.

[129]  R. Gaynor,et al.  Protein Phosphatase 2Cβ Association with the IκB Kinase Complex Is Involved in Regulating NF-κB Activity* , 2003, Journal of Biological Chemistry.

[130]  Chou-Long Huang,et al.  On the Role of Pore Helix in Regulation of TRPV5 by Extracellular Protons , 2006, The Journal of Membrane Biology.

[131]  Yuji Arai,et al.  A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor–regulated channel , 2003, The Journal of cell biology.

[132]  N. Dean,et al.  Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression* , 2003, The Journal of Biological Chemistry.

[133]  Antonio Ferrer-Montiel,et al.  Attenuation of thermal nociception and hyperalgesia by VR1 blockers , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[134]  M. Freichel,et al.  Trp12, a novel Trp related protein from kidney , 2000, FEBS letters.

[135]  T. Baumann,et al.  Extracellular Protons Both Increase the Activity and Reduce the Conductance of Capsaicin- Gated Channels , 2000, The Journal of Neuroscience.

[136]  M. Iadarola,et al.  Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1 , 2007, Proceedings of the National Academy of Sciences.

[137]  A. Davis,et al.  Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[138]  S. Hwang,et al.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  D. Barford,et al.  Molecular basis for TPR domain‐mediated regulation of protein phosphatase 5 , 2005, The EMBO journal.

[140]  A. Patapoutian,et al.  Two amino acid residues determine 2-APB sensitivity of the ion channels TRPV3 and TRPV4 , 2009, Proceedings of the National Academy of Sciences.

[141]  T. Veenstra,et al.  Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites , 2003, Current Biology.

[142]  L. Vyklický,et al.  Gadolinium activates and sensitizes the vanilloid receptor TRPV1 through the external protonation sites , 2005, Molecular and Cellular Neuroscience.

[143]  F. Porteu,et al.  B56‐containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX‐1 and ERK , 2006, The EMBO journal.

[144]  M. van der Stelt,et al.  Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. , 2004, European journal of biochemistry.

[145]  J. Treanor,et al.  Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[146]  D. J. Brasier,et al.  Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[147]  John B. Hogenesch,et al.  A Heat-Sensitive TRP Channel Expressed in Keratinocytes , 2002, Science.

[148]  Stephen P. H. Alexander,et al.  Guide to Receptors and Channels, 2nd edition (2007 Revision) , 2007 .

[149]  M. Ikekita,et al.  A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells , 2003, British journal of pharmacology.

[150]  J. Mi,et al.  ATM regulates ionizing radiation-induced disruption of HDAC1:PP1:Rb complexes. , 2007, Cellular signalling.

[151]  Zoltan Szallasi,et al.  Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[152]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[153]  D. Clapham,et al.  Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels , 2006, Nature Neuroscience.

[154]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[155]  A. Basbaum,et al.  The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli , 1998, Neuron.

[156]  A. Takai,et al.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. , 1988, The Biochemical journal.

[157]  V. Esser,et al.  Have we overlooked the importance of serine/threonine protein phosphatases in pancreatic beta-cells? Role played by protein phosphatase 2A in insulin secretion. , 2005, JOP : Journal of the pancreas.

[158]  David E. Clapham,et al.  TRPV3 is a calcium-permeable temperature-sensitive cation channel , 2002, Nature.

[159]  P. Wipf,et al.  Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. , 2005, Annual review of pharmacology and toxicology.

[160]  Y. Suh,et al.  Activation and activators of TRPV1 and their pharmaceutical implication. , 2005, Current pharmaceutical design.

[161]  M. Bollen,et al.  Functional diversity of protein phosphatase-1, a cellular economizer and reset button. , 2004, Physiological reviews.

[162]  M. Roberge,et al.  Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. , 1994, Cancer research.

[163]  M. Kanzaki,et al.  Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I , 1999, Nature Cell Biology.

[164]  W. T. Beck,et al.  Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme. , 1993, Cancer research.

[165]  G. Ahern.  Activation of TRPV1 by the Satiety Factor Oleoylethanolamide* , 2003, Journal of Biological Chemistry.

[166]  R. Colbran,et al.  A Protein Phosphatase-1γ1 Isoform Selectivity Determinant in Dendritic Spine-associated Neurabin* , 2004, Journal of Biological Chemistry.

[167]  D. Boger,et al.  Fostriecin: chemistry and biology. , 2002, Current medicinal chemistry.

[168]  D. Boger,et al.  Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition. , 2003, Journal of the American Chemical Society.

[169]  T. Neelands,et al.  Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia. , 2008, European journal of pharmacology.

[170]  B. Wadzinski,et al.  Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit. , 1999, The Biochemical journal.

[171]  P. Pasricha,et al.  Modulation of TRPV 1 by nonreceptor tyrosine kinase , cSrc kinase , 2004 .

[172]  Michael A Berman,et al.  RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. , 2006, Molecular cell.

[173]  M. Tominaga,et al.  Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. , 2002, Journal of neurophysiology.

[174]  Ping-Hui Tseng,et al.  Histone Acetylation-independent Effect of Histone Deacetylase Inhibitors on Akt through the Reshuffling of Protein Phosphatase 1 Complexes* , 2005, Journal of Biological Chemistry.

[175]  Michael A. Briggs,et al.  The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor. , 2008, Bioorganic & medicinal chemistry letters.

[176]  S. Simon,et al.  Similarities and differences in the currents activated by capsaicin, piperine, and zingerone in rat trigeminal ganglion cells. , 1996, Journal of neurophysiology.

[177]  J. Panten,et al.  Monoterpenoid agonists of TRPV3 , 2007, British journal of pharmacology.

[178]  J. Byrd,et al.  FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. , 2008, Blood.

[179]  K. Becker,et al.  Doxorubicin-resistant LoVo adenocarcinoma cells display resistance to apoptosis induction by some but not all inhibitors of ser/thr phosphatases 1 and 2A. , 1999, Toxicology.

[180]  K. Jeang,et al.  Human T-lymphotropic Virus Type I Tax Activates I-κB Kinase by Inhibiting I-κB Kinase-associated Serine/Threonine Protein Phosphatase 2A* , 2003, The Journal of Biological Chemistry.

[181]  Antonio Ferrer-Montiel,et al.  Physiology and pharmacology of the vanilloid receptor. , 2006, Current neuropharmacology.

[182]  R. Sears,et al.  Protein Phosphatase 2A Regulatory Subunit B56α Associates with c-Myc and Negatively Regulates c-Myc Accumulation , 2006, Molecular and Cellular Biology.

[183]  M. Tominaga,et al.  Lipophilicity of capsaicinoids and capsinoids influences the multiple activation process of rat TRPV1. , 2006, Life sciences.

[184]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[185]  U. Wissenbach,et al.  Differential activation of the volume-sensitive cation channel TRP12 (OTRPC4) and volume-regulated anion currents in HEK-293 cells , 2001, Pflügers Archiv.

[186]  Laura M. Heiser,et al.  Regulation of the Raf–MEK–ERK pathway by protein phosphatase 5 , 2006, Nature Cell Biology.

[187]  G. Crabtree,et al.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation , 1992, Nature.

[188]  P. Cohen.  Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.

[189]  Anton Meinhart,et al.  Structure and mechanism of RNA polymerase II CTD phosphatases. , 2004, Molecular cell.

[190]  T. Hutchinson,et al.  Activation Properties of Heterologously Expressed Mammalian TRPV2 , 2007, Journal of Biological Chemistry.

[191]  J. Treanor,et al.  Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade , 2007, Journal of Pharmacology and Experimental Therapeutics.

[192]  P. Hofmann,et al.  Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.

[193]  D. Armstrong,et al.  Purification of a Fatty Acid-stimulated Protein-serine/threonine Phosphatase from Bovine Brain and Its Identification as a Homolog of Protein Phosphatase 5* , 1997, The Journal of Biological Chemistry.

[194]  S. Pfaff,et al.  Small CTD Phosphatases Function in Silencing Neuronal Gene Expression , 2005, Science.

[195]  Guido Marcucci,et al.  The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. , 2005, Cancer cell.

[196]  Wade Morishita,et al.  Regulation of Synaptic Strength by Protein Phosphatase 1 , 2001, Neuron.

[197]  E. Mayer,et al.  Protease-Activated Receptor 2 Sensitizes the Capsaicin Receptor Transient Receptor Potential Vanilloid Receptor 1 to Induce Hyperalgesia , 2004, The Journal of Neuroscience.

[198]  E. Ciszak,et al.  Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5* , 2004, Journal of Biological Chemistry.

[199]  David J. Chen,et al.  DNA-PKcs function regulated specifically by protein phosphatase 5. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[200]  J. Hoenderop,et al.  Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. , 2000, Journal of the American Society of Nephrology : JASN.

[201]  P. Reeh,et al.  The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. , 2008, The Journal of clinical investigation.

[202]  D. Ron,et al.  Endoplasmic reticulum stress signaling in disease. , 2006, Physiological reviews.

[203]  Bernd Nilius,et al.  TRPV4 calcium entry channel: a paradigm for gating diversity. , 2004, American journal of physiology. Cell physiology.

[204]  Ji-Min Kim,et al.  N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. , 2003, Journal of medicinal chemistry.

[205]  Patricia T W Cohen,et al.  Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.

[206]  S. Durell,et al.  Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1. , 2006, Biochemistry.

[207]  K. Srinivasan,et al.  Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects , 2007, Critical reviews in food science and nutrition.

[208]  Ji-Bin Peng,et al.  WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. , 2007, American journal of physiology. Renal physiology.

[209]  Clifford J. Woolf,et al.  Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers , 2007, Nature.

[210]  J. Hoenderop,et al.  The ß-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel , 2005, Science.

[211]  B. Nilius,et al.  Mg 2 (cid:2) -dependent Gating and Strong Inward Rectification of the Cation Channel TRPV6 , 2003 .

[212]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[213]  M. Masu,et al.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[214]  H. Ropers,et al.  MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation , 2001, Nature Genetics.

[215]  Roberto Dominguez,et al.  Structural basis of protein phosphatase 1 regulation , 2004, Nature.

[216]  M. Caligiuri,et al.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. , 2007, The Journal of clinical investigation.

[217]  D. Hartshorne,et al.  Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. , 2008, Developmental cell.

[218]  G. Schultz,et al.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity , 2000, Nature Cell Biology.

[219]  B. Wadzinski,et al.  Protein Phosphatase 2A Interacts with and Directly Dephosphorylates RelA* , 2001, The Journal of Biological Chemistry.

[220]  R. Colbran,et al.  Selective targeting of the γ1 isoform of protein phosphatase 1 to F‐actin in intact cells requires multiple domains in spinophilin and neurabin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[221]  B. Nilius,et al.  Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels , 2003, Nature.

[222]  Hwa-Young Kim,et al.  Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[223]  T. Sugimoto,et al.  Vanilloid receptor 1-like receptor-immunoreactive primary sensory neurons in the rat trigeminal nervous system , 2000, Neuroscience.

[224]  A. Ullrich,et al.  Targeting polo-like kinase 1 for cancer therapy , 2006, Nature Reviews Cancer.

[225]  Marilyn E Morris,et al.  MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells , 2009, Molecular Pharmacology.

[226]  P. Pasricha,et al.  Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. , 2004, American journal of physiology. Cell physiology.

[227]  Wenqing Xu,et al.  Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme , 2007, Nature.

[228]  M. Karin,et al.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.

[229]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[230]  M. Caterina,et al.  Biphasic Currents Evoked by Chemical or Thermal Activation of the Heat-gated Ion Channel, TRPV3* , 2005, Journal of Biological Chemistry.

[231]  Guofei Zhou,et al.  Ser/Thr Protein Phosphatase 5 Inactivates Hypoxia-induced Activation of an Apoptosis Signal-regulating Kinase 1/MKK-4/JNK Signaling Cascade* , 2004, Journal of Biological Chemistry.

[232]  B. Nilius,et al.  The TRPV4 channel: structure-function relationship and promiscuous gating behaviour , 2003, Pflügers Archiv.

[233]  A. Minassi,et al.  Development of the First Ultra-Potent “Capsaicinoid” Agonist at Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels and Its Therapeutic Potential , 2005, Journal of Pharmacology and Experimental Therapeutics.

[234]  W. Hahn,et al.  Identification of specific PP2A complexes involved in human cell transformation. , 2004, Cancer cell.

[235]  P. Greengard,et al.  Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP–32 and spinophilin , 1999, Nature Neuroscience.

[236]  D. Clapham,et al.  Camphor Activates and Strongly Desensitizes the Transient Receptor Potential Vanilloid Subtype 1 Channel in a Vanilloid-Independent Mechanism , 2005, The Journal of Neuroscience.

[237]  A. Moqrich,et al.  Impaired Thermosensation in Mice Lacking TRPV3, a Heat and Camphor Sensor in the Skin , 2005, Science.

[238]  B. Moosmann,et al.  Statin-Induced Liver Injury Involves Cross-Talk between Cholesterol and Selenoprotein Biosynthetic Pathways , 2009, Molecular Pharmacology.

[239]  H. Salazar,et al.  A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic , 2008, Nature Neuroscience.

[240]  D. Virshup,et al.  Protein serine/threonine phosphatases: life, death, and sleeping. , 2005, Current opinion in cell biology.

[241]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[242]  P. Houillier,et al.  Tissue kallikrein stimulates Ca2+ reabsorption via PKC‐dependent plasma membrane accumulation of TRPV5 , 2006, The EMBO journal.

[243]  I. Kojima,et al.  Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages , 2007, Journal of cellular physiology.

[244]  G. Stemp,et al.  N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1. , 2006, Bioorganic & medicinal chemistry letters.

[245]  S. Hwang,et al.  Phosphorylation of Vanilloid Receptor 1 by Ca2+/Calmodulin-dependent Kinase II Regulates Its Vanilloid Binding* , 2004, Journal of Biological Chemistry.

[246]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[247]  K. Mackie,et al.  Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[248]  V. Marzo,et al.  New perspectives on enigmatic vanilloid receptors , 2000, Trends in Neurosciences.

[249]  S. Ackland,et al.  Norcantharidin Analogues: Synthesis, Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition , 2008, ChemMedChem.

[250]  Albert J. Fornace,et al.  Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis , 2005, Cancer biology & therapy.

[251]  Xiao-Fan Wang,et al.  Protein Phosphatase 5 Is Required for ATR-Mediated Checkpoint Activation , 2005, Molecular and Cellular Biology.

[252]  S. Ghosh,et al.  Phosphorylation of Serine 68 in the IκB Kinase (IKK)-binding Domain of NEMO Interferes with the Structure of the IKK Complex and Tumor Necrosis Factor-α-induced NF-κB Activity* , 2008, Journal of Biological Chemistry.

[253]  Péter Lénárt,et al.  BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo , 2007, Current Biology.

[254]  R. Honkanen,et al.  Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? , 2002, Current medicinal chemistry.

[255]  R. Busse,et al.  Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium , 2005, Circulation research.

[256]  Tada-aki Kudo,et al.  PP2C family members play key roles in regulation of cell survival and apoptosis , 2006, Cancer science.

[257]  D. Clapham,et al.  Bisandrographolide from Andrographis paniculata Activates TRPV4 Channels* , 2006, Journal of Biological Chemistry.

[258]  K. Mori,et al.  Galpha(12) and Galpha(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. , 2002, Current biology : CB.

[259]  Philip R. Cohen,et al.  Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1 , 1997, The EMBO journal.

[260]  Yohimbine inhibits firing activities of rat dorsal root ganglion neurons by blocking Na+ channels and vanilloid VR1 receptors. , 2004, European journal of pharmacology.

[261]  D. J. Brasier,et al.  cAMP-Dependent Protein Kinase Regulates Desensitization of the Capsaicin Receptor (VR1) by Direct Phosphorylation , 2002, Neuron.

[262]  A. Ferrer-Montiel,et al.  Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity* , 2004, Journal of Biological Chemistry.

[263]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[264]  A. Akopian,et al.  The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[265]  S. Barik.  Immunophilins: for the love of proteins , 2006, Cellular and Molecular Life Sciences CMLS.

[266]  G. Stemp,et al.  Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1. , 2008, Bioorganic & medicinal chemistry letters.

[267]  M. Mumby,et al.  The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation , 1993, Cell.

[268]  P. Wipf,et al.  Dual-specificity phosphatases as targets for antineoplastic agents , 2002, Nature Reviews Drug Discovery.

[269]  Junying Yuan,et al.  ICP34.5-dependent and -independent activities of salubrinal in herpes simplex virus-1 infected cells. , 2008, Virology.

[270]  G. Courtois,et al.  Mutations in the NF-kappaB signaling pathway: implications for human disease. , 2006, Oncogene.

[271]  A. Penna,et al.  PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane. , 2006, Cell calcium.

[272]  G. Appendino,et al.  Protective effect of capsinoid on lipid peroxidation in rat tissues induced by Fe-NTA , 2005, Free radical research.

[273]  Lawrence A. Donehower,et al.  Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D , 2007, Journal of Neuro-Oncology.

[274]  B. Nilius,et al.  Mg2+-dependent Gating and Strong Inward Rectification of the Cation Channel TRPV6 , 2003, The Journal of general physiology.

[275]  M. Sodeoka,et al.  Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). , 2003, Journal of the American Chemical Society.

[276]  P. Steyger,et al.  TRPV1 regulators mediate gentamicin penetration of cultured kidney cells , 2005, Hearing Research.

[277]  N. Chen,et al.  Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides. , 2005, Journal of medicinal chemistry.

[278]  M. Valverde,et al.  IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5′-6′-epoxyeicosatrienoic acid , 2008, The Journal of cell biology.

[279]  A. Penna,et al.  Pharmacological characterization and molecular determinants of the activation of TRPV2 channel orthologs by 2-aminoethoxydiphenyl borate , 2007 .

[280]  Mark T. Kershaw,et al.  Aminoquinazolines as TRPV1 antagonists: modulation of drug-like properties through the exploration of 2-position substitution. , 2008, Bioorganic & medicinal chemistry letters.

[281]  A. Minassi,et al.  The role of natural products in the ligand deorphanization of TRP channels. , 2008, Current pharmaceutical design.

[282]  Craig Montell,et al.  The TRP Superfamily of Cation Channels , 2005, Science's STKE.

[283]  A. Depaoli-Roach,et al.  Cyclin G2 Associates with Protein Phosphatase 2A Catalytic and Regulatory B′ Subunits in Active Complexes and Induces Nuclear Aberrations and a G1/S Phase Cell Cycle Arrest* , 2002, The Journal of Biological Chemistry.

[284]  R. Vennekens,et al.  Herbal Compounds and Toxins Modulating TRP Channels , 2008, Current neuropharmacology.

[285]  P. McNaughton,et al.  Why Pain Gets Worse: The Mechanism of Heat Hyperalgesia , 2006, The Journal of general physiology.

[286]  K. Mori,et al.  Gα12 and Gα13 Interact with Ser/Thr Protein Phosphatase Type 5 and Stimulate Its Phosphatase Activity , 2002, Current Biology.

[287]  S. Ackland,et al.  Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. , 2007, Bioorganic & medicinal chemistry letters.

[288]  S. Pelech,et al.  Positive Regulation of Raf1-MEK1/2-ERK1/2 Signaling by Protein Serine/Threonine Phosphatase 2A Holoenzymes* , 2005, Journal of Biological Chemistry.

[289]  Z. Jia,et al.  Protein phosphatases: structures and implications. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[290]  M. Chen,et al.  A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. , 1994, The EMBO journal.

[291]  J. Singh,et al.  Piperine impairs cytochrome P4501A1 activity by direct interaction with the enzyme and not by down regulation of CYP1A1 gene expression in the rat hepatoma 5L cell line. , 1996, Biochemical and biophysical research communications.

[292]  W. Kolch,et al.  Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation* , 2000, The Journal of Biological Chemistry.

[293]  D. Clapham,et al.  Citral Sensing by TRANSient Receptor Potential Channels in Dorsal Root Ganglion Neurons , 2008, PloS one.

[294]  W. Hahn,et al.  Involvement of PP2A in viral and cellular transformation , 2005, Oncogene.

[295]  V. Ramkumar,et al.  Direct Interaction of Adenosine with the TRPV1 Channel Protein , 2004, The Journal of Neuroscience.

[296]  A. Ferrer-Montiel,et al.  Identification of an Aspartic Residue in the P-loop of the Vanilloid Receptor That Modulates Pore Properties* , 2000, The Journal of Biological Chemistry.

[297]  T. Hutchinson,et al.  TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons , 2008, The Journal of Neuroscience.

[298]  Takeshi Imamura,et al.  Protein Phosphatase 2A Forms a Molecular Complex with Shc and Regulates Shc Tyrosine Phosphorylation and Downstream Mitogenic Signaling , 2002, Molecular and Cellular Biology.

[299]  Michael D. Davis,et al.  The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.

[300]  A. Hudspeth,et al.  Vanilloid Receptor–Related Osmotically Activated Channel (VR-OAC), a Candidate Vertebrate Osmoreceptor , 2000, Cell.

[301]  Jae Hyun Kim,et al.  Activation of Vanilloid Receptor 1 (VR1) by Eugenol , 2003, Journal of dental research.

[302]  H. Koerber,et al.  Artemin Overexpression in Skin Enhances Expression of TRPV1 and TRPA1 in Cutaneous Sensory Neurons and Leads to Behavioral Sensitivity to Heat and Cold , 2006, The Journal of Neuroscience.

[303]  A. Weidema,et al.  Regulation of the Mouse Epithelial Ca2+ Channel TRPV6 by the Ca2+-sensor Calmodulin* , 2004, Journal of Biological Chemistry.

[304]  R. Vennekens,et al.  Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1 , 2001, British journal of pharmacology.

[305]  M. Montminy,et al.  The Phosphorylation Status of a Cyclic AMP-Responsive Activator Is Modulated via a Chromatin-Dependent Mechanism , 2000, Molecular and Cellular Biology.

[306]  J. Hoenderop,et al.  The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[307]  M. Wagatsuma,et al.  Cloning and characterization of a novel subunit of protein serine/threonine phosphatase 4 from mesangial cells. , 2001, Journal of the American Society of Nephrology : JASN.

[308]  B. Fiedler,et al.  Targeting calcineurin and associated pathways in cardiac hypertrophy and failure , 2005, Expert opinion on therapeutic targets.

[309]  P. Blumberg,et al.  Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper , 1989, Neuroscience.

[310]  J. Steinbach,et al.  Activation and Modulation of Concatemeric GABA-A Receptors Expressed in Human Embryonic Kidney Cells , 2009, Molecular Pharmacology.

[311]  Canhui Li,et al.  A Small-Molecule Modulator Interacts Directly with ΔPhe508-CFTR to Modify Its ATPase Activity and Conformational Stability , 2009, Molecular Pharmacology.

[312]  P. Wyman,et al.  Discovery of small molecule antagonists of TRPV1. , 2004, Bioorganic & medicinal chemistry letters.

[313]  A. Kulkarni,et al.  Cdk5: A New Player in Pain Signaling , 2006, Cell cycle.

[314]  B. Nilius,et al.  Sensing with TRP channels , 2005, Nature chemical biology.

[315]  Vladimir A. Pavlyukovets,et al.  Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists. , 2007, Bioorganic & medicinal chemistry.

[316]  Jin Kwan Kim,et al.  Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents. , 2005, Journal of medicinal chemistry.

[317]  Michael J Caterina,et al.  2-Aminoethoxydiphenyl Borate Activates and Sensitizes the Heat-Gated Ion Channel TRPV3 , 2004, The Journal of Neuroscience.

[318]  Joel D. Sanneman,et al.  Vitamin D upregulates expression of ECaC1 mRNA in semicircular canal. , 2005, Biochemical and biophysical research communications.

[319]  G. Wagner,et al.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[320]  M. Zhu,et al.  Potentiation of TRPV3 channel function by unsaturated fatty acids , 2006, Journal of cellular physiology.

[321]  S. Hamilton,et al.  Regulation of ryanodine receptors by FK506 binding proteins. , 2004, Trends in cardiovascular medicine.

[322]  T. Veldman,et al.  Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells , 2002, Journal of Virology.

[323]  B. Nilius,et al.  Determinants of 4α-Phorbol Sensitivity in Transmembrane Domains 3 and 4 of the Cation Channel TRPV4* , 2007, Journal of Biological Chemistry.

[324]  Bernd Nilius,et al.  Vanilloid transient receptor potential cation channels: an overview. , 2008, Current pharmaceutical design.

[325]  Kai Long,et al.  A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. , 2005, Science.

[326]  John D. Scott,et al.  Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo , 2002, Nature Cell Biology.

[327]  Anna Tempczyk,et al.  Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex , 1995, Nature.

[328]  P. Reeh,et al.  A high‐threshold heat‐activated channel in cultured rat dorsal root ganglion neurons resembles TRPV2 and is blocked by gadolinium , 2007, The European journal of neuroscience.

[329]  J. Treanor,et al.  Proton Activation Does Not Alter Antagonist Interaction with the Capsaicin-Binding Pocket of TRPV1 , 2005, Molecular Pharmacology.

[330]  Marc Flajolet,et al.  Discovery of protein phosphatase 2C inhibitors by virtual screening. , 2006, Journal of medicinal chemistry.

[331]  박옥희.  Vanilloid receptor 길항제의 분자설계 및 합성 , 2001 .

[332]  M. Pauza,et al.  Sensitization and translocation of TRPV1 by insulin and IGF-I , 2005, Molecular pain.

[333]  J. Hoenderop,et al.  Concerted action of associated proteins in the regulation of TRPV5 and TRPV6. , 2007, Biochemical Society transactions.

[334]  R. Honkanen,et al.  Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A , 1997, FEBS letters.

[335]  N. Onishi,et al.  Intrinsic Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by Wip1* , 2006, Journal of Biological Chemistry.

[336]  K. Reynolds,et al.  Enhancement and Selective Production of Phoslactomycin B, a Protein Phosphatase IIa Inhibitor, through Identification and Engineering of the Corresponding Biosynthetic Gene Cluster* , 2003, Journal of Biological Chemistry.